C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 403/14 (2006.01) A61K 31/506 (2006.01) A61K 31/5377 (2006.01) A61K 31/541 (2006.01) A61P 35/00 (2006.01) C07D 401/14 (2006.01) C07D 409/14 (2006.01) C07D 413/14 (2006.01) C07D 417/14 (2006.01) C07D 471/04 (2006.01)
Patent
CA 2659582
The present invention relates to 4-indol-3-yl-N-phenylpyrimidin-2-amine derivatives, that are useful for treating cellular proliferative diseases, for treating disorders associated with MET activity, and for inhibiting the receptor tyrosine kinase MET. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.
La présente invention concerne des dérivés de 4-indol-3-yl-N-phénylpyrimidin-2-amine qui se révèlent utiles pour le traitement de maladies liées à la prolifération cellulaire, pour le traitement de troubles associés à l'activité du récepteur MET, et pour l'inhibition du récepteur MET de la tyrosine kinase. L'invention concerne également des compositions qui contiennent ces composés, et des procédés destinés à les utiliser pour traiter le cancer chez des mammifères.
Kozina Ekaterina S.
Siu Tony
Gowling Lafleur Henderson Llp
Merck & Co. Inc.
LandOfFree
Tyrosine kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tyrosine kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tyrosine kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1353790